Sign in

You're signed outSign in or to get full access.

Kristin Stafford

Director at T Stamp
Board

About Kristin Stafford

Independent director at T Stamp Inc. (Trust Stamp). A serial entrepreneur in SaaS for global compliance and background screening; co-founder and CEO of Vital4 since February 2016, with >20 years’ experience in operations management, process architecture, and software development . Age 54 (as of the 2024 proxy nomination) . Board independence affirmed by the company under Nasdaq rules; serves on Audit and Nominating & Corporate Governance Committees .

Past Roles

OrganizationRoleTenureCommittees/Impact
International Screening Solutions, Inc.Co-founder and Managing Partner2009–2015 Built multi-million-dollar platform later sold to Dun & Bradstreet in 2021
Delta TechnologySenior ConsultantNot disclosed Financial operations/process architecture contributions
Northern Trust BankSenior ConsultantNot disclosed Financial operations/process architecture contributions
GE Capital (start-up division)Management roleNot disclosed Operations systems management/software development leadership

External Roles

OrganizationRoleTenureNotes
Vital4 (Vital4Data, Inc.)Co-founder and CEOSince Feb 2016 Global cloud platform for compliance and background screening

Board Governance

  • Independence: Company determined Kristin Stafford is independent under Nasdaq and SEC rules .
  • Committees: Audit Committee member (Chair: Charles Potts; committee includes Potts, McClintock, Stafford; Potts is the audit committee financial expert) . Nominating & Corporate Governance Committee member (Chair: William McClintock) . Not on Compensation Committee .
  • Board leadership: Chairman of the Board is William McClintock; the company separates CEO and Chair roles and holds executive sessions of independent directors .
  • Attendance: Company invites and encourages directors to attend stockholder meetings; specific individual attendance rates not disclosed .

Fixed Compensation

  • Director compensation disclosure is aggregate only: directors, as a group, were paid $234,000 for services in FY2024; individual director cash retainers, meeting fees, and chair fees are not disclosed .
  • Company notes Nominating & Corporate Governance Committee reviews and determines director compensation arrangements, but specific amounts are not provided .

Performance Compensation

  • Equity plan: Company states it does not have a formal equity incentive plan; executives received RSUs; director equity specifics by individual largely not disclosed .
  • Outstanding equity awards (as of Dec 31, 2024): Stafford shows no unvested stock awards or options; other directors (e.g., Potts, McClintock) have RSUs; performance metrics for director compensation are not disclosed .

Other Directorships & Interlocks

  • CEO of Vital4; the company has an existing mutual channel agreement with Vital4Data, Inc. where Vital4 acts as a non-exclusive sales representative for Trust Stamp; commission structure is 20% in year one, 10% in year two, 5% in year three. No commissions were earned or expensed under this agreement through Dec 31, 2024 and June 30, 2025 .
  • No public company directorships for Stafford are disclosed .

Expertise & Qualifications

  • Specialized in SaaS and enterprise platforms for compliance and background screening; led teams >100; strong operations systems management and software development background .
  • Industry entrepreneur with product/platform commercialization; relevant to data integrity, screening, and compliance oversight—skills additive to audit and governance work .

Equity Ownership

MetricSep 30, 2024Jan 29, 2025Sep 30, 2025
Shares beneficially owned234 16 16
% of shares outstanding—% (not shown for 234; total base 18,819,750) —% (de minimis; total base 2,200,046) 0.00% (rounded; table shows “—%”)
Vested vs unvested sharesNot disclosed Not disclosed No unvested awards shown for Stafford
Options (exercisable/unexercisable)None disclosed None disclosed None disclosed
Shares pledged as collateralNot disclosedNot disclosedNot disclosed
Ownership guidelines complianceNot disclosedNot disclosedNot disclosed

Governance Assessment

  • Independence and committee roles: Positive—independent status and membership on Audit and Nominating committees, with the Audit Committee responsible for related-party review and financial controls .
  • Ownership alignment: Weak—minuscule personal shareholding (16 shares; effectively 0% of outstanding), with no disclosed director-specific equity grants or ownership guidelines. This lowers “skin-in-the-game” alignment .
  • Potential conflicts: Related-party channel agreement with Vital4/Vital4Data, where Stafford is CEO; while no commissions have accrued to date, the structure creates an ongoing conflict vector requiring rigorous Audit Committee oversight (commission-based payments tied to Trust Stamp sales) .
  • Attendance transparency: Company broadly encourages meeting attendance; no per-director attendance stats disclosed, limiting assessment of engagement .
  • Board structure: Separation of Chair and CEO and independent executive sessions are governance positives; Audit Committee has a designated financial expert .
  • Financing backdrop: Concentrated warrant/holder dynamics (e.g., Armistice beneficial ownership via warrants) indicate capital structure volatility; not directly a Stafford issue but relevant to oversight context .

RED FLAGS

  • Related-party arrangement with Vital4/Vital4Data presents conflict risk; requires ongoing disclosure and independent review; zero commissions to date reduces immediate economic impact but the incentive mechanics remain .
  • Very low personal ownership and no disclosed director equity grants for Stafford diminishes alignment with shareholders .

Monitoring suggestions for investors

  • Track any commissions recognized under the Vital4/Vital4Data agreement and whether terms are modified; confirm Audit Committee approval and disclosure in future filings .
  • Seek disclosure of director-level compensation structure (cash retainer, committee fees, equity awards) to assess pay-for-performance and alignment .
  • Request per-director attendance and engagement metrics in future proxies to evaluate board effectiveness .

Sources: Corporate governance, committee assignments, independence, and related-party disclosures from Trust Stamp DEF 14A (Nov 12, 2025) ; biography and role details from DEF 14A (Dec 12, 2024) and Form 10-K FY2024/FY2023 ; beneficial ownership tables from DEF 14A (Dec 26, 2024; Mar 28, 2025; Nov 12, 2025) ; outstanding equity awards table .